Jane Robertson, MD
Jane Robertson, MD
Executive Global Clinical Director
AstraZeneca
Alderley Park
Macclesfield
United Kingdom
SK10 4TF
Papers:
14
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multi-study sub-analysis